Pfizer (NYSE: PFE)stock hasn't been a big winner so far in 2018. On the other hand, the big pharma stock is beating the S&P 500index at this point. And there will soon be a potential catalyst that could provide a spark.
What to Expect with Pfizer's Q1 Results
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться